相关实验视频
Updated: Oct 12, 2025

12:04
Microfluidic Preparation of Liquid Crystalline Elastomer Actuators
Published on: May 20, 2018
9.1K
形状保存单晶到无形到单晶多态转换是可能的
Olivier Renier1, Guillaume Bousrez1, Glib V Baryshnikov2,3
1Department of Materials and Environmental Chemistry, Stockholm University, 10691 Stockholm, Sweden.
Journal of the American Chemical Society
|November 23, 2021
概括
现在可以详细研究晶体材料中的多态相过渡,如化物复合物. 我们观察到一种缓慢的形状保存转变, 通过一种无形的中间体,
科学领域:
- 固态化学
- 晶体学
- 材料科学
背景情况:
- 晶体材料通常以多态的形式存在,在不同的温度或压力下经历固体-固体的转变.
- 了解这些多态变化的精确机制仍然是一个重大挑战,因为它们的速度通常很快.
- 目前的机械学见解通常通过比较过渡前和过渡后的晶体结构来推断,从而限制了详细的理解.
研究的目的:
- 研究晶体材料中的多态相变的机制.
- 挑战普遍的假设,即在形状保存的多态转换过程中保持结晶性.
- 阐明固体变化中中间阶段的作用.
主要方法:
- 单晶X射线衍射分析
- 在 ZnCl2 ((1,3-diethylimidazole-2-thione) 2 多态体中缓慢的固态相转换的观察
- 介质无形阶段的表征
主要成果:
- 在ZnCl2 ((1,3-diethylimidazole-2-thione) 2中观察到的多态转化异常缓慢.
- 这种转化是通过一种无形的中间阶段进行的.
- 在整个单晶到单晶转换过程中保持了形状的保存.
结论:
- 这项研究揭示了一种涉及无形中间体的多态相过渡的新机制.
- 这一发现挑战了长期以来的观点,即在保持形状的固体变化过程中保持晶体性.
- 这种特定转变的缓慢速度使得以前无法获得的详细机械洞察力成为可能.
相关概念视频
Polymer Classification: Crystallinity
3.3K
Unlike ionic or small covalent molecules, polymers do not form crystalline solids due to the diffusion limitations of their long-chain structures. However, polymers contain microscopic crystalline domains separated by amorphous domains.
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
3.3K
Crystal Growth: Principles of Crystallization
3.1K
Crystallization is a phase transformation process in which crystals are precipitated from a supersaturated solution or formed from other sources. During crystallization, atoms or molecules arrange themselves into a well-defined, rigid crystal lattice to minimize energy.
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent...
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent...
3.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
423
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
423
Recrystallization: Solid–Solution Equilibria
1.5K
Recrystallization is a purification technique used to separate impurities from solid compounds. In this technique, no chemical reactions occur. Instead, it exploits physical properties only, specifically, the solubility differences between the desired compound and impurities, either at a single temperature or at different temperatures, and under other selected conditions. The solid-solution equilibrium (solubility equilibrium) of each component in the solution represents a binary phase...
1.5K

